Author: admin

RIYADH, Saudi Arabia, Oct. 28, 2024 /PRNewswire/ — Twelve international companies have been added to the FII Institute’s roster of Strategic Partners. These companies join a growing community of leaders from business, technology, aviation, energy, academia, and public policy committed t

At three years, over 80% of patients with moderately to severely active UC who were in remission with mirikizumab sustained long-term remission and relief from disruptive symptoms, including bowel urgency Mirikizumab also helped over 50% of patients with moderately to severely active Crohn’s d

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: